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The great therapeutic potential of
human embryonic stem (ES) cells
(see Box) and the thorny ethical
issues surrounding their use have
prompted many governments to
revisit existing regulations on embryo
research (see Table on next page).
Just in recent weeks, the Canadian
government proposed regulatory
guidelines that would allow the
derivation and use of ES cells from
human embryos but, unlike
legislation that was passed earlier this
year in the United Kingdom, would
outlaw the creation of embryos for
research purposes. Meanwhile, in the
United States the National Institutes
of Health (NIH) called off its review
of research proposals that make use
of ES cells — the first to be
submitted since the moratorium on
federally funded research in this area
was lifted last year. The issue as to
whether NIH should fund embryo
research is currently under review by
Health and Human Services
Secretary Tommy Thompson.
The proposed Canadian law,
submitted to a parliamentary
committee by Liberal Health
Minister Allan Rock, deals with all
aspects of reproductive technology,
including embryo research. It
advocates that research on stem cells
from human embryos that have been
created by in vitro fertilization should
be allowed under strict guidelines.
However, all human cloning
(regardless of whether it is for
therapeutic or reproductive purposes)
and the creation of embryos to obtain
stem cells are banned. According to
Janet Rossant, co-head of the
program in development and fetal
health at the Samuel Lunenfeld
Research Institute in Toronto,
Canada, the scientific community is
supportive of the legislation because
“we want to see research with human
embryos move forward and to do that
you need clear regulatory
guidelines.”
Rossant was chair of an ad hoc
Working Group on Stem Cell
Research formed at the request of
the Canadian Institutes of Health
Research (CIHR, a funding agency
analogous to the NIH). The group’s
recommendations to allow CIHR
funding of human ES cell research
but not the creation of embryos for
research purposes or the creation of
human–animal chimeras were
released for public comment on
April 29 and will serve as the basis for
CIHR to develop guidelines for
funding stem cell research. 
Although the proposed CIHR
guidelines cover only publicly
funded research, the CIHR urged
the government to create a national
body to oversee all stem cell
research, so that private and public
sector would abide to the same
guidelines. The legislation to be
introduced to Canadian parliament
proposes to do just that. However,
according to Rossant, how the
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As the US government ponders the fate of stem cell research, two recent reports by US
scientists — one dealing with embryonic and the other with adult stem cells — provide
evidence of the therapeutic potential of this research.
In one report published on Science’s website on April 26 scientists coaxed mouse
embryonic stem cells in a dish to form three-dimensional clusters that look and act like islets
of Langerhans in the pancreas — the structures responsible for producing and secreting
insulin in response to blood sugar levels. According to senior author Ron McKay of the
National Institutes of Health, the differentiated cells produce insulin through the same
mechanisms that are used in vivo. The work suggests that cells derived from human
embryos could be transplanted into diabetic patients who lack functional pancreatic islets.
What is even more exciting to McKay than the therapeutic potential of this work is that these
cells assemble in the right architecture, mimicking what happens during organogenesis.
“We have shown that stem cells are capable of self-assembly,” says McKay. The islets
worked properly when transplanted into diabetic mice but they only produced 2% of the
insulin, a level too low to normalize the animals’ blood sugar levels. “What this tells us is that
we have not done it all,” says McKay.
The second report, published in the May 4 issue of Cell, showed that a single bone-marrow
derived stem cell is capable not only of reconstituting the bone marrow when transplanted
to irradiated mice but also of developing into epithelial cells of multiple organs (including the
intestines, lung, and skin). “We were greatly excited to find 20% differentiation in the lung
tissue 11 months post transplant of individual adult hematopoietic stem cells,” says Saul
Sharkis, author of the study and director of the experimental hematopoiesis program at
Johns Hopkins Medical Institute. The results of the study also indicate that adult stem cells
might be summoned to sites of injury to differentiate into multiple types of cells, suggesting
that these stem cells might be able to repair damaged tissues throughout the body and
serve as treatment for a variety of diseases characterized by tissue and organ damage.
However, Sharkis cautions that “it is clearly too soon to predict any therapeutic application
for these adult cells.” Sharkis also said that it is too early to draw any comparisons between
the level of plasticity of adult versus embryonic stem cells.
The promise of stem cell research
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regulatory body will function under
the proposed legislation still needs to
be worked out. One possibility is that
“it might be like the HFEA [Human
Fertilisation and Embryology
Authority] in the United Kingdom,”
says Rossant.
The regulations proposed for
Canadian scientists might end up
being more liberal than those
adopted in the United States, at least
for federally funded researchers. At
the moment the NIH cannot fund
any embryo research. 
After the Clinton administration
lifted the moratorium on NIH-
funded embryo research, the NIH
laid out specific guidelines that were
published in August 2000. The
guidelines limited funding to the use
of human ES cells taken from frozen
spare embryos from fertility clinics
and already destined to be discarded
and obtained with the informed
consent of the donating couples. But,
unlike the proposed regulations in
Canada, US federal funds could not
be used to destroy the embryos to
obtain the cells. In other words,
privately funded researchers would
have to pass them on to federally
supported scientists. 
All NIH-funded research
proposing to use human pluripotent
stem cells was to undergo the regular
scientific peer-review as well as a
formal review of documentation of
compliance with the NIH guidelines
by the Human Pluripotent Stem Cell
Review Group (HPSCRG).
The decision to call off the first
meeting of the HPSCRG and to
review current guidelines has left
many US scientists concerned that
they will be cut off from an important
area of research. Another concern is
that if NIH does not fund this type
of research, funding will be left to
private organizations and individuals,
which, in the absence of legislation,
are largely unregulated.
A new coalition including the
American Society for Cell Biology,
the Juvenile Diabetes Foundation,
and Harvard University, which calls
itself the Coalition for the
Advancement of Medical Research
was established in March to put
pressure on the government to
support ES cell research. In addition,
earlier this year 80 Nobel laureates
sent a letter to President Bush
indicating that “it is premature to
conclude that adult stem cells have
the same potential as embryonic
stem cells” and that research on both
fronts should be continued.
Meanwhile, in April Republicans
introduced to US Congress two
separate bills that would ban somatic
cell nuclear transfer using human
cells (human cloning) regardless of
whether the technique is used in
research or reproduction. The ban
would affect both publicly and
privately funded research.
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Table
National regulations on embryo research in different countries.
Country Regulations
Austria Embryo research is forbidden. Embryos may be created only so far as is 
required to ensure a pregnancy. No supernumerary (spare) embryos are 
created. 
Germany Under the embryo protection law, it is illegal to derive cells from an embryo 
for research or diagnosis. In May 2001, the Deutsche Forschungsgemein-
schaft (DGF), the main public funding body for biomedical research, 
recommended that embryo stem cell research be allowed.
Italy There is no law specifically concerned with research on human embryos. 
However, the Italian Health Minister gave support to a report published in 
December 2000 by a group of scientific experts that supports the cloning 
of human embryos for the derivation of stem cells for therapeutic purposes.
Finland Specific legislation that entered into force in November 1999 forbids the 
creation of embryos for the purpose of research.
Ireland and Norway Any research on in vitro embryos, stem cells, or cloning is prohibited.
Canada In 1995, the government imposed a voluntary moratorium on the creation of 
embryos for research purposes and human embryo cloning. This year, The 
Human Reproductive and Genetic Technologies Bill was introduced to 
Parliament; it bans cloning but allows research on supernumerary human 
embryos prior to 14 days of development. 
Netherlands Proposed legislation presented to parliament in September 2000 would 
allow research on embryonic stem cells derived from supernumerary 
embryos for purposes other than the pregnancy. The proposed regulation 
would not allow the creation of embryos for research purposes.
France Legislation passed in 1994 prohibits experimentation on embryos. Prime 
Minister M. Lionel Jospin presented draft legislation that would allow 
nuclear transfer technology to develop therapeutic applications from 
embryonic stem cells. The proposal will be put before parliament in 2001.
United States The National Institutes of Health (NIH) published in August 2000 
guidelines that authorize research on human stem cells taken from frozen 
embryos from fertility clinics and are destined to be discarded. The NIH 
guidelines are applicable to the private sector on a voluntary basis. The 
guidelines are currently under review by the secretary of Health and Human 
Services.
Japan The Human Cloning Regulation Act adopted by Japanese Parliament in 
November 2000 authorizes research on supernumerary embryos and the 
creation of embryos by somatic nuclear transfer for stem cell research. The 
act enters into force in June 2001.
United Kingdom Legislation took effect in January 2001 to permit licensing of research in 
which human embryos are created for specific purposes, including for the 
derivation of stem cells. Research projects must be approved by the Human 
Fertilisation and Embryology Authority.
